2D ex vivo patient derived acute myeloid leukemia platform for evaluation of novel molecular targeted therapeutic agents

被引:0
|
作者
Verma, Bhavna [1 ]
Biel, Nikolett [1 ]
Wesa, Amy [1 ]
机构
[1] Champ Oncol Inc, Rockville, MD USA
关键词
D O I
10.1158/1538-7445.AM2020-6298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6298
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Patient-Derived Acute Myeloid Leukemia (AML) Ex Vivo platform for Evaluation of Novel Molecular Targeted Therapeutic Agents
    Verma, Bhavna
    Biel, Nicolett
    Ruggeri, Bruce
    Wesa, Amy
    [J]. BLOOD, 2019, 134
  • [2] Establishment of a patient-derived acute myeloid leukemia (AML) ex vivo platform for evaluation of novel therapeutic agents
    Verma, Bhavna
    Tati, Swetha
    Ruggeri, Bruce
    Wesa, Amy
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Establishment of a Patient-Derived Acute B Lymphoblastic Leukemia (B-ALL) Ex Vivo and In Vivoplatform for Evaluation of Novel Therapeutic Agents
    Vishwakarma, Bandana Ajay
    Verma, Bhavna
    Biel, Nicolett
    Wesa, Amy
    [J]. BLOOD, 2020, 136
  • [4] Novel therapeutic agents in acute myeloid leukemia
    Stone, Richard M.
    [J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (04) : 163 - 166
  • [5] EX VIVO EVALUATION OF THE CYTOTOXICITY IN ACUTE MYELOID LEUKEMIA PATIENTS
    Podgornik, Helena
    Mikolic, Veronika
    Rebersek, Katarina
    Sever, Matjaz
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 116 - 116
  • [6] A Patient-Specific Ex Vivo Screening Platform for Personalized Acute Myeloid Leukemia (AML) Therapy
    Azzam, Diana
    Volmar, Claude-Henry
    Hassan, Al-Ali
    Perez, Aymee
    Watts, Justin M.
    Vargas, Fernando
    Elias, Roy
    Vega, Francisco
    Zelent, Arthur
    Cogle, Christopher R.
    Wahlestedt, Claes
    Swords, Ronan T.
    [J]. BLOOD, 2015, 126 (23)
  • [7] In vitro and in vivo model for evaluation of novel therapeutic agents in patient-derived acute B-lymphoblastic leukemia (B-ALL).
    Vishwakarma, Bandana Ajay
    Verma, Bhavna
    Wesa, Amy
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [8] Novel Agents for the Treatment of Acute Myeloid Leukemia in the Older Patient
    Baer, Maria R.
    Gojo, Ivana
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (03): : 331 - 335
  • [9] In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia
    Gopalakrishnapillai, Anilkumar
    Kaeding, Allison
    Schatz, Christoph
    Sommer, Anette
    Meshinchi, Soheil
    Kolb, E. Anders
    Barwe, Sonali
    [J]. BLOOD, 2019, 134
  • [10] Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy
    Guo, Jianfeng
    Russell, Eileen G.
    Darcy, Raphael
    Cotter, Thomas G.
    McKenna, Sharon L.
    Cahill, Mary R.
    O'Driscoll, Caitriona M.
    [J]. MOLECULAR PHARMACEUTICS, 2017, 14 (03) : 940 - 952